World's 1st trial deliberately infecting young adults with COVID-19 found to be safe | Inquirer News

World’s 1st trial deliberately infecting young adults with COVID-19 found to be safe

/ 05:36 PM February 02, 2022

Open Orphan project - infecting adults with COVID-19

Test tube with Coronavirus label is seen in this illustration taken on January 29, 2020. | PHOTO: REUTERS/Dado Ruvic

LONDON — The world’s first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.

The data supports the safety of this model which could theoretically provide a “plug and play” platform for testing therapies and vaccines using the original COVID-19 strain as well as variants of the virus, Open Orphan, which carried out the study, said in a statement.

Article continues after this advertisement

Open Orphan is running the project, launched a year ago, with Imperial College London, the UK government’s vaccines task force and the clinical company  hVIVO.

FEATURED STORIES

The trial infected 36 healthy male and female volunteers aged 18-29 years with the original SARS-CoV-2 strain of the virus and closely monitored them in a controlled quarantined setting. They will be followed up for 12 months after discharge from the quarantine facility.

No serious adverse events occurred, and the human challenge study model was shown to be safe and well tolerated in healthy young adults, the company said.

Article continues after this advertisement

With the model established, it said it should be able to contract or conduct COVID-19 human challenge studies in 2022, subject to individual ethics and regulatory approvals.

RELATED STORIES
Britain backs slew of ‘long COVID’ research studies
Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment
Wanted: Volunteers to catch COVID in the name of science

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, Research

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.